WO2009106338A2 - Composition cosmétique ou dermopharmaceutique de micelles mixtes - Google Patents

Composition cosmétique ou dermopharmaceutique de micelles mixtes Download PDF

Info

Publication number
WO2009106338A2
WO2009106338A2 PCT/EP2009/001405 EP2009001405W WO2009106338A2 WO 2009106338 A2 WO2009106338 A2 WO 2009106338A2 EP 2009001405 W EP2009001405 W EP 2009001405W WO 2009106338 A2 WO2009106338 A2 WO 2009106338A2
Authority
WO
WIPO (PCT)
Prior art keywords
agents
cosmetic
dermopharmaceutical
skin
composition according
Prior art date
Application number
PCT/EP2009/001405
Other languages
English (en)
Other versions
WO2009106338A3 (fr
Inventor
Olga Lopez Serrano
Alfonso De La Maza
Lucyanna Barbosa
José María GARCÍA ANTÓN
Juan CEBRIÁN PUCHE
Nuria ALMIÑANA DOMÉNECH
Original Assignee
Lipotec, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec, S.A. filed Critical Lipotec, S.A.
Publication of WO2009106338A2 publication Critical patent/WO2009106338A2/fr
Publication of WO2009106338A3 publication Critical patent/WO2009106338A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0291—Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Definitions

  • liposome refers to an approximately spherical aggregate formed by at least one double layer or bilayer of at least one phospholipid wherein the layers are very close to one another and the apolar domains of each layer are faced towards the apolar domains of the other lipid layer and thus, the polar domains of the phospholipids form both the internal and the external face of the double layer or bilayer.
  • the phospholipid of the composition micelles of the present invention is a natural or synthetic phosphoglyceride and preferably it is selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylethanolamine, phosphatidylcholine, phosphatide acid, phosphatidyl lycerol, diphosphatidylglycerol, phosphorylcholine, cardiolipin, fatty acid esters thereof, hydrogenation products thereof and the mixtures thereof, such as for example and in a non- ⁇ imiting sense, egg, soy or sunflower lecithins.
  • fatty acids there are for example and in a non-limiting sense, stearic, palmitic, oleic, myristic, lauric acids and all those saturated and unsaturated fatty acids known in the state of the art.
  • phosphatidylcholine LIPOID ® S 100 [INCI: Phosphatidylcholine] were added with stirring, followed by 3 g of tocopherol acetate, and next, 0.4 g of xanthane gum. Finally, 30 g of OPxAMIX CG 110 [INCI: Water (Aqua), Caprylyl/Capryl Glucoside] at 60% were added slowly with stirring so as not to make foam and it was brought up to volume with water up to 100 ml.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une composition cosmétique ou dermopharmaceutique de micelles mixtes de phospholipide tensioactif qui sont reconstituées dans la couche cornée de la peau, et son utilisation pour le traitement et/ou le soin de la peau, des cils, des cheveux et/ou des ongles.
PCT/EP2009/001405 2008-02-29 2009-02-27 Composition cosmétique ou dermopharmaceutique de micelles mixtes WO2009106338A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200800596A ES2335636B1 (es) 2008-02-29 2008-02-29 Composicion cosmetica o dermofarmaceutica de micelas mixtas.
ESP200800596 2008-02-29

Publications (2)

Publication Number Publication Date
WO2009106338A2 true WO2009106338A2 (fr) 2009-09-03
WO2009106338A3 WO2009106338A3 (fr) 2010-02-25

Family

ID=41016508

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/001405 WO2009106338A2 (fr) 2008-02-29 2009-02-27 Composition cosmétique ou dermopharmaceutique de micelles mixtes

Country Status (2)

Country Link
ES (1) ES2335636B1 (fr)
WO (1) WO2009106338A2 (fr)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120057242A (ko) * 2010-11-26 2012-06-05 (주)아모레퍼시픽 스프레이 타입의 에어로졸 화장료 조성물
CN103212109A (zh) * 2013-04-17 2013-07-24 王伟 一种理疗巾芯片
WO2013171131A1 (fr) * 2012-05-14 2013-11-21 Sequessome Technology Holdings Ltd Formulations vésiculaires, leurs utilisations et procédés
ITRM20120267A1 (it) * 2012-06-08 2013-12-09 Antonio Chiarella Formulazione liquida micronizzabile per il trattamento terapeutico dell'acne e di altre patologie cutanee correlate
WO2015014965A1 (fr) * 2013-07-31 2015-02-05 Pro Bono Bio International Trading Ltd Vésicules
US9452179B2 (en) 2009-08-21 2016-09-27 Sequessome Technology Holdings Limited Vesicular formulations
WO2017001625A1 (fr) * 2015-06-30 2017-01-05 Sequessome Technology Holdings Limited Compositions multiphasiques
US9555051B2 (en) 2012-03-29 2017-01-31 Sequessome Technology Holdings Limited Vesicular formulations
EP2802337B1 (fr) 2011-11-07 2018-03-21 Feng Tian Composés à base de peptide en tant qu'inhibiteurs de la sécrétion d'un neurotransmetteur
CN109330994A (zh) * 2018-11-28 2019-02-15 杭州普施康生物科技有限公司 一种榄香烯固体脂质纳米粒及其制备方法
US10966914B2 (en) 2017-06-14 2021-04-06 Counter Brands, Llc Skin mimicking emulsion
EA039827B1 (ru) * 2013-07-31 2022-03-17 Ооо "Про Боно Био" Везикулярная композиция
US11369552B1 (en) 2020-09-11 2022-06-28 Elena Yurievna Komarova Aqueous nail polish remover
CN115282081A (zh) * 2022-07-05 2022-11-04 浙江东印化妆品有限公司 一种高效美白淡斑修印功效组合物及应用
IT202200002549A1 (it) * 2022-02-11 2023-08-11 Sferalp Sa Metodo per la preparazione di un olio formulato per la formazione di una dispersione micellare in acqua e composizione di olio realizzata con il detto metodo
CN116570733B (zh) * 2023-07-13 2023-10-13 四川大学华西医院 一种具有多功能的核壳壳结构药物胶束及其制备方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102961779B (zh) * 2012-12-04 2014-10-22 深圳市宜丽环保科技有限公司 一种植物抑菌除味功能的卫生巾芯片
CN113226277B (zh) * 2018-12-26 2023-12-01 日本精化株式会社 美白剂、透明质酸产生促进剂、胶原蛋白产生促进剂、细胞内活性氧清除剂、刺激缓解剂、皱纹改善剂、复合物、化妆品和皮肤外用剂

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747066A (en) * 1995-03-07 1998-05-05 Hoffmann-La Roche Inc. Mixed micelles
WO1999022703A1 (fr) * 1997-10-31 1999-05-14 Lurident Ltd. Formulations ameliorees de soins personnels
US6303109B1 (en) * 1997-03-12 2001-10-16 Henkel Kommanditgesellschaft Auf Aktien Body cleansing agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080046650A (ko) * 2005-08-05 2008-05-27 바스프 카탈리스트 엘엘씨 디젤 배기가스 처리 장치 및 이것을 위한 촉매 조성물

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747066A (en) * 1995-03-07 1998-05-05 Hoffmann-La Roche Inc. Mixed micelles
US6303109B1 (en) * 1997-03-12 2001-10-16 Henkel Kommanditgesellschaft Auf Aktien Body cleansing agent
WO1999022703A1 (fr) * 1997-10-31 1999-05-14 Lurident Ltd. Formulations ameliorees de soins personnels

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A. M. FADDA AND AL.: "Phospholipid-detergent systems: effects of polysorbates on the release of liposomal caffeine" IL FARMACO, no. 53, 1998, pages 650-654, XP002559871 *
DATABASE WPI Section Ch, Week 200873 Thomson Scientific, London, GB; Class A96, AN 2008-M34228 XP002560029 -& CN 101 287 550 A (UNIV SHENYANG MEDICAL) 12 March 2008 (2008-03-12) *

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9452179B2 (en) 2009-08-21 2016-09-27 Sequessome Technology Holdings Limited Vesicular formulations
KR20120057242A (ko) * 2010-11-26 2012-06-05 (주)아모레퍼시픽 스프레이 타입의 에어로졸 화장료 조성물
KR101684909B1 (ko) * 2010-11-26 2016-12-09 (주)아모레퍼시픽 스프레이 타입의 에어로졸 화장료 조성물
EP2802337B1 (fr) 2011-11-07 2018-03-21 Feng Tian Composés à base de peptide en tant qu'inhibiteurs de la sécrétion d'un neurotransmetteur
US9555051B2 (en) 2012-03-29 2017-01-31 Sequessome Technology Holdings Limited Vesicular formulations
WO2013171131A1 (fr) * 2012-05-14 2013-11-21 Sequessome Technology Holdings Ltd Formulations vésiculaires, leurs utilisations et procédés
ITRM20120267A1 (it) * 2012-06-08 2013-12-09 Antonio Chiarella Formulazione liquida micronizzabile per il trattamento terapeutico dell'acne e di altre patologie cutanee correlate
CN103212109A (zh) * 2013-04-17 2013-07-24 王伟 一种理疗巾芯片
GB2533235A (en) * 2013-07-31 2016-06-15 Sequessome Tech Holdings Ltd Vesicles
WO2015014965A1 (fr) * 2013-07-31 2015-02-05 Pro Bono Bio International Trading Ltd Vésicules
GB2533235B (en) * 2013-07-31 2018-11-21 Sequessome Tech Holdings Limited Vesicles
EA039827B1 (ru) * 2013-07-31 2022-03-17 Ооо "Про Боно Био" Везикулярная композиция
US11547665B2 (en) 2015-06-30 2023-01-10 Sequessome Technology Holdings Limited Multiphasic compositions
WO2017001625A1 (fr) * 2015-06-30 2017-01-05 Sequessome Technology Holdings Limited Compositions multiphasiques
US10744090B2 (en) 2015-06-30 2020-08-18 Sequessome Technology Holdings Limited Multiphasic compositions
EA038208B1 (ru) * 2015-06-30 2021-07-23 Секвессом Текнолоджи Холдингс Лимитед Многофазные композиции
EP3954361A1 (fr) * 2015-06-30 2022-02-16 Sequessome Technology Holdings Limited Compositions multiphasiques
US10966914B2 (en) 2017-06-14 2021-04-06 Counter Brands, Llc Skin mimicking emulsion
CN109330994A (zh) * 2018-11-28 2019-02-15 杭州普施康生物科技有限公司 一种榄香烯固体脂质纳米粒及其制备方法
US11369552B1 (en) 2020-09-11 2022-06-28 Elena Yurievna Komarova Aqueous nail polish remover
IT202200002549A1 (it) * 2022-02-11 2023-08-11 Sferalp Sa Metodo per la preparazione di un olio formulato per la formazione di una dispersione micellare in acqua e composizione di olio realizzata con il detto metodo
CN115282081A (zh) * 2022-07-05 2022-11-04 浙江东印化妆品有限公司 一种高效美白淡斑修印功效组合物及应用
CN116570733B (zh) * 2023-07-13 2023-10-13 四川大学华西医院 一种具有多功能的核壳壳结构药物胶束及其制备方法

Also Published As

Publication number Publication date
ES2335636A1 (es) 2010-03-30
WO2009106338A3 (fr) 2010-02-25
ES2335636B1 (es) 2011-05-11

Similar Documents

Publication Publication Date Title
ES2335636B1 (es) Composicion cosmetica o dermofarmaceutica de micelas mixtas.
KR102217951B1 (ko) 피부，점막 및／또는 손발톱의 치료 및／또는 관리를 위한 엑소폴리사카라이드
ES2336995B1 (es) Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
ES2384060B1 (es) Cápsulas de nanopartículas lipídicas.
CA2818723C (fr) Exopolysaccharide pour le traitement et/ou les soins de la peau, des membranes muqueuses, des cheveux et/ou des ongles
KR101979462B1 (ko) 마이크로에멀젼을 포함하는 나노캡슐
CN116370397A (zh) 包含来自南极假交替单胞菌的细菌细胞外产物的化妆品和/或药物组合物及其用途
CN105451710A (zh) 用于治疗和/或护理皮肤、粘膜和/或指甲的外泌多糖
ES2654345T3 (es) Exopolisacárido para el tratamiento y/o el cuidado de la piel, membranas mucosas, cabello y/o uñas
CN116687780A (zh) 含多肽的靶向渗透组合物及其应用

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09714783

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 09714783

Country of ref document: EP

Kind code of ref document: A2